Currently there are no specific regulations governing the sale of OTC products and this impacts both patient safety and access, says OPPI
IPA says it is bringing industry and regulators together to address these concerns
Action is taken when firms are found selling products at a price which is 10% higher than the MRP
The project aims to set up common facilities for companies and upgrade any existing one